1. Home
  2. VTS vs ESPR Comparison

VTS vs ESPR Comparison

Compare VTS & ESPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vitesse Energy Inc.

VTS

Vitesse Energy Inc.

HOLD

Current Price

$18.19

Market Cap

752.5M

Sector

Energy

ML Signal

HOLD

Logo Esperion Therapeutics Inc.

ESPR

Esperion Therapeutics Inc.

HOLD

Current Price

$3.13

Market Cap

731.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VTS
ESPR
Founded
2014
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
752.5M
731.9M
IPO Year
2022
2013

Fundamental Metrics

Financial Performance
Metric
VTS
ESPR
Price
$18.19
$3.13
Analyst Decision
Hold
Strong Buy
Analyst Count
1
4
Target Price
$20.00
$8.75
AVG Volume (30 Days)
406.6K
16.9M
Earning Date
05-04-2026
05-07-2026
Dividend Yield
11.91%
N/A
EPS Growth
N/A
60.71
EPS
N/A
N/A
Revenue
$273,989,000.00
$403,135,000.00
Revenue This Year
$5.48
N/A
Revenue Next Year
N/A
$12.81
P/E Ratio
N/A
N/A
Revenue Growth
13.22
21.31
52 Week Low
$17.22
$0.79
52 Week High
$27.15
$4.18

Technical Indicators

Market Signals
Indicator
VTS
ESPR
Relative Strength Index (RSI) 45.97 70.22
Support Level $17.42 $3.11
Resistance Level $20.13 $3.18
Average True Range (ATR) 0.50 0.02
MACD -0.00 0.01
Stochastic Oscillator 41.53 21.43

Price Performance

Historical Comparison
VTS
ESPR

About VTS Vitesse Energy Inc.

Vitesse Energy Inc is an independent energy company focused on returning capital to stockholders through owning interests as a non-operator in oil and natural gas wells. It is engaged in the acquisition, development, and production of non-operated oil and natural gas properties in the United States that are generally operated by oil companies and are in the Williston Basin of North Dakota and Montana with limited operations. The company also have properties in the Central Rockies, including the Denver-Julesburg Basin and the Powder River Basin.

About ESPR Esperion Therapeutics Inc.

Esperion Therapeutics Inc is a commercial-stage biopharmaceutical company currently focused on bringing new medicines to patients that address unmet medical needs. It has developed and is commercializing U.S. Food and Drug Administration, or FDA, approved oral, once-daily, non-statin medicines for patients who are at risk for cardiovascular disease (or CVD and are struggling with elevated low-density lipoprotein cholesterol, or LDL-C. The Company views its operations and manages its business in one operating segment, which is the business of researching, developing, and commercializing therapies for the treatment of patients with elevated LDL-C. The company depends almost entirely on the success of two products, the bempedoic acid tablet and the bempedoic acid/ezetimibe combination tablet.

Share on Social Networks: